New tests of early cancer detection will allow the implementation of better treatments through personalized medicine
Although its personalized medicine`s products aren’t in the market yet, the test for early colon cancer detection, ‘ColoFast’, might be available the next year in the European Union and the United States of America. How do Amadix’s advances benefit cancer patients? Find out below. Amadix is a Spanish biotech company founded in 2010 that develops […]